Low prevalence of thrombophilic coagulation defects in patients with deep veto thrombosis of the upper limbs

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 3, 1997, Pages 191-194

  Ruggeri, M ^b   Castaman, G ^b   Tosetto, A ^b   Rodeghiero, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b NONE

Author keywords

anticardiolipin antibodies; deep venous thrombosis; Inherited coagulation defects

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY;

EID: 0030990337     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199704000-00006     Document Type: Article

References (13)

1. Bolgiano EB, Foxwell MM, Browne BJ, Barish RA. Deep venous thrombosis of the upper extremity: diagnosis and treatment. J Emergency Med 1990; 8: 85-91.
2. Heijboer H, Brandjes DPM, Buller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep vein thrombosis. N Engl J Mcd 1990; 323: 1512-1516.
3. Svensonn PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522.
4. Horattas MC, Wright DJ, Fenton AH, et al. Changing concept of deep venous thrombosis of the upper extremity - report of a series and review of the literature. Surgery 1988; 104: 561-567.
5. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-151.
6. Rodeghiero F, Tosetto A. The VITA Project: population-based distribution of protein C, antithrombin III, heparin cofactor II and plasminogen. Relationship with physiological variables and establishment of reference ranges. Thromb Haemost 1996; 76: 226-233.
7. Tosetto A, Rodeghiero F. Diagnosis of APC resistance in patients on oral anticoagulant therapy. Thromb Haemost 1995; 73: 732-733.
8. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74: 449-453.
9. Rochester JR, Beard JD. Acute management of subclavian vein thrombosis. Br J Surg 1995; 82: 433-434.
10. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes and management. Blood 1996; 87: 3531-3544.
11. De Stefano V, Leone G, Mastrangelo S, et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb Haemost 1994; 72: 352-358.
12. Palareti G, Legnani C, Ludovici S, Boggian O, Coccheri S. Prevalence of high levels of antiphospholipid antibodies in otherwise unexplained juvenile venous thromboembolism. Thromb Haemost 1991; 65: 452-453.
13. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibodies syndrome. N Engl J Med 1995; 332: 993-997.